Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer.
about
Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?Treatment experiences of Latinas after diagnosis of breast cancer.Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.Personomics: The Missing Link in the Evolution from Precision Medicine to Personalized Medicine.Influence of provider factors and race on uptake of breast cancer gene expression profiling.Ginkgolic acids induce HepG2 cell death via a combination of apoptosis, autophagy and the mitochondrial pathway.
P2860
Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Chemotherapy decisions and pat ...... for early-stage breast cancer.
@en
Chemotherapy decisions and pat ...... for early-stage breast cancer.
@nl
type
label
Chemotherapy decisions and pat ...... for early-stage breast cancer.
@en
Chemotherapy decisions and pat ...... for early-stage breast cancer.
@nl
prefLabel
Chemotherapy decisions and pat ...... for early-stage breast cancer.
@en
Chemotherapy decisions and pat ...... for early-stage breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Chemotherapy decisions and pat ...... for early-stage breast cancer.
@en
P2093
Allison W Kurian
Ann S Hamilton
Christopher R Friese
Irina Bondarenko
Kevin C Ward
Steven J Katz
Timothy P Hofer
P2860
P356
10.1002/CNCR.30324
P407
P577
2016-10-24T00:00:00Z